Attached files

file filename
10-K - ANNUAL REPORT - IMMUCELL CORP /DE/f10k2016_immucellcorp.htm
EX-32 - CERTIFICATION - IMMUCELL CORP /DE/f10k2016ex32_immucell.htm
EX-31 - CERTIFICATION - IMMUCELL CORP /DE/f10k2016ex31_immucell.htm
EX-23 - CONSENT OF BAKER NEWMAN & NOYES, LLC - IMMUCELL CORP /DE/f10k2016ex23_immucell.htm
EX-10.24 - MORTGAGE LOAN NOTE FOR $340,000 GIVEN BY THE COMPANY IN FAVOR OF TD BANK N.A. DA - IMMUCELL CORP /DE/f10k2016ex10xxiv_immucell.htm
EX-10.18 - AMENDMENT TO CONSTRUCTION LOAN AGREEMENT BETWEEN THE COMPANY AND TD BANK N.A. DA - IMMUCELL CORP /DE/f10k2016ex10xviii_immucell.htm
EX-10.17 - AMENDED AND RESTATED PROMISSORY NOTE ($3,940,000) GIVEN BY THE COMPANY IN FAVOR - IMMUCELL CORP /DE/f10k2016ex10xvii_immucell.htm
EX-10.16 - AMENDED AND RESTATED PROMISSORY NOTE ($2,560,000) GIVEN BY THE COMPANY IN FAVOR - IMMUCELL CORP /DE/f10k2016ex10xvi_immucell.htm

EXHIBIT 23.1

 

 

IMMUCELL CORPORATION

 

CONSENT OF RSM US LLP

 

CONSENT OF INDEPENDENT Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statements (Nos. 333-207635 and 333-214641) on Form S-3 and the Registration Statements (Nos. 333-02631, 333-65514, and 333-167721) on Form S-8 of ImmuCell Corporation of our report dated March 30, 2017, relating to our audit of the financial statements as of and for the year ended December 31, 2016, which appears in this Annual Report on Form 10-K of ImmuCell Corporation for the year ended December 31, 2016.

  

/s/ RSM US LLP  
   
Boston, Massachusetts  
March 30, 2017